MetP Pharma
About MetP® Pharma AG MetP® Pharma AG is an independent, specialized pharmaceutical R&D company based in Switzerland. The company has developed an advanced and comprehensively patented nose-to-brain drug delivery system allowing to bypass the blood-brain barrier. The company's internal product development program includes intranasal products for the indications concussion, insomnia, attention deficit hyperactivity disorder (ADHD) and multiple sclerosis (MS). MetP® also provides pharmaceutical development and manufacture services based on its proprietary and worldwide patented intranasal delivery technology. MetP®'s single-dose nasal applicator Lecticula® was among the finalists for the 2016 CPhI Pharma Award in the category "Excellence in Pharma: Drug Delivery Devices".